Home / Inspections / 1027967

FDA Inspection 1027967 — Avadel Legacy Pharmaceuticals LLC

Avadel Legacy Pharmaceuticals LLC — FEI 3008832322

The FDA completed an inspection of Avadel Legacy Pharmaceuticals LLC on October 6, 2017 in Chesterfield, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 6, 2017
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Chesterfield, MO (United States)

Facility

Other inspections at this facility

  • 1091059 (NAI Wed Apr 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1068774 (NAI Thu Oct 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 946968 (VAI Wed Sep 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 859453 (NAI Mon Dec 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 762688 (NAI Wed Nov 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources